MindWalk

American AI drug-discovery company (Nasdaq: HYFT), formerly ImmunoPrecise Antibodies

HYFT Nasdaq ISIN CA45257F2008 SEC CIK 1715925
Follow MindWalk Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 CAD · IFRS
Revenue, last quarter CAD 4.2M +52.4% vs same quarter last year
Net income −CAD 3.9M +81.7% vs same quarter last year
EPS, diluted -
Operating cash flow −CAD 3M −147% vs same quarter last year
Revenue by quarter
CAD 6.5M
CAD 2.5M
CAD 2.7M
CAD 2.7M
CAD 16.6M
CAD 3.2M
CAD 4.1M
CAD 4.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−CAD 40M−CAD 20MCAD 0CAD 20MCAD 40MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25CAD 24.5M−CAD 30.2M
FY24CAD 24.5M−CAD 26.1M
FY23CAD 20.7M−CAD 26.6M
FY22CAD 19.4M−CAD 16.7M
FY21CAD 17.9M−CAD 7.3M
FY20CAD 14.1M−CAD 4.9M
FY19--
MarginsShare of revenue
  • Gross margin
  • Net margin
−150%−100%−50%0%50%100%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginNet margin
FY2555.3%−123.3%
FY2449.2%−106.5%
FY2356%−128.5%
FY2256.7%−86.3%
FY2164.4%−41%
FY2057.1%−35.2%
FY19--
Free cash flowOperating cash flow minus capital expenditure
−CAD 30M−CAD 20M−CAD 10MCAD 0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−CAD 7.2M
FY24−CAD 4.6M
FY23−CAD 21.3M
FY22−CAD 11M
FY21−CAD 2M
FY20−CAD 1.8M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • MindWalk
  • Healthcare median
−150%−100%−50%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearMindWalkHealthcare median
FY25−123.3%−30.6%
FY24−106.5%−47%
FY23−128.5%−58%
FY22−86.3%−80.4%
FY21−41%−71.9%
FY20−35.2%−62.2%
FY19-−46.3%